320 related articles for article (PubMed ID: 28123825)
1. No association of
Yang TT; He Y; Xiang YJ; Ao DH; Wang YY; Zhang Q; He XJ; Zhong SS; Wu J; Liu GZ
Transl Neurosci; 2016; 7(1):76-83. PubMed ID: 28123825
[TBL] [Abstract][Full Text] [Related]
2. Lack of association between AQP4 polymorphisms and risk of inflammatory demyelinating disease in a Korean population.
Park TJ; Kim JH; Kim HJ; Bae JS; Cheong HS; Park BL; Shin HD
Gene; 2014 Feb; 536(2):302-7. PubMed ID: 24361961
[TBL] [Abstract][Full Text] [Related]
3. Pattern-specific loss of aquaporin-4 immunoreactivity distinguishes neuromyelitis optica from multiple sclerosis.
Roemer SF; Parisi JE; Lennon VA; Benarroch EE; Lassmann H; Bruck W; Mandler RN; Weinshenker BG; Pittock SJ; Wingerchuk DM; Lucchinetti CF
Brain; 2007 May; 130(Pt 5):1194-205. PubMed ID: 17282996
[TBL] [Abstract][Full Text] [Related]
4. Common genetic variants in PRRC2A are associated with both neuromyelitis optica spectrum disorder and multiple sclerosis in Han Chinese population.
Zhang J; Chen MJ; Zhao GX; Li HF; Wu L; Xu YF; Liao Y; Yuan Z; Wu ZY
J Neurol; 2021 Feb; 268(2):506-515. PubMed ID: 32862241
[TBL] [Abstract][Full Text] [Related]
5. Loss of aquaporin 4 in lesions of neuromyelitis optica: distinction from multiple sclerosis.
Misu T; Fujihara K; Kakita A; Konno H; Nakamura M; Watanabe S; Takahashi T; Nakashima I; Takahashi H; Itoyama Y
Brain; 2007 May; 130(Pt 5):1224-34. PubMed ID: 17405762
[TBL] [Abstract][Full Text] [Related]
6. Increased occurrence of anti-AQP4 seropositivity and unique HLA Class II associations with neuromyelitis optica (NMO), among Muslim Arabs in Israel.
Brill L; Mandel M; Karussis D; Petrou P; Miller K; Ben-Hur T; Karni A; Paltiel O; Israel S; Vaknin-Dembinsky A
J Neuroimmunol; 2016 Apr; 293():65-70. PubMed ID: 27049564
[TBL] [Abstract][Full Text] [Related]
7. Genetic analysis of the aquaporin-4 gene for anti-AQP4 antibody-positive neuromyelitis optica in a Japanese population.
Ogasawara M; Meguro A; Sakai T; Mizuki N; Takahashi T; Fujihara K; Tsuneoka H; Shikishima K
Jpn J Ophthalmol; 2016 May; 60(3):198-205. PubMed ID: 27012886
[TBL] [Abstract][Full Text] [Related]
8. Distinct genetic and infectious profiles in Japanese neuromyelitis optica patients according to anti-aquaporin 4 antibody status.
Yoshimura S; Isobe N; Matsushita T; Yonekawa T; Masaki K; Sato S; Kawano Y; Kira J;
J Neurol Neurosurg Psychiatry; 2013 Jan; 84(1):29-34. PubMed ID: 23038741
[TBL] [Abstract][Full Text] [Related]
9. NMO spectrum disorders comprise the major portion of CNS inflammatory diseases in Thai patients: A cross sectional study.
Apiwattanakul M; Kasemsuk C
Mult Scler Relat Disord; 2014 Jan; 3(1):61-6. PubMed ID: 25877974
[TBL] [Abstract][Full Text] [Related]
10. Autoimmunity in neuromyelitis optica and opticospinal multiple sclerosis: astrocytopathy as a common denominator in demyelinating disorders.
Kira J
J Neurol Sci; 2011 Dec; 311(1-2):69-77. PubMed ID: 21962794
[TBL] [Abstract][Full Text] [Related]
11. [Recent progress in multiple sclerosis research: astrocytopathy in demyelinating diseases].
Kira J
Rinsho Shinkeigaku; 2010 Nov; 50(11):788-93. PubMed ID: 21921443
[TBL] [Abstract][Full Text] [Related]
12. Loss of aquaporin-4 in active perivascular lesions in neuromyelitis optica: a case report.
Misu T; Fujihara K; Nakamura M; Murakami K; Endo M; Konno H; Itoyama Y
Tohoku J Exp Med; 2006 Jul; 209(3):269-75. PubMed ID: 16778375
[TBL] [Abstract][Full Text] [Related]
13. Autoimmune AQP4 channelopathies and neuromyelitis optica spectrum disorders.
Hinson SR; Lennon VA; Pittock SJ
Handb Clin Neurol; 2016; 133():377-403. PubMed ID: 27112688
[TBL] [Abstract][Full Text] [Related]
14. ABCB1 gene polymorphisms impact the effect of high-dose intravenous methylprednisolone therapy on optic neuritis associated with AQP4-IgG-positive neuromyelitis optica spectrum disorder.
Dai Y; Ni S; Wu F; Guo S; Zhao X; Wang J
J Clin Pharm Ther; 2022 Sep; 47(9):1379-1387. PubMed ID: 35488449
[TBL] [Abstract][Full Text] [Related]
15. Neuromyelitis optica spectrum disorder: Pathogenesis, treatment, and experimental models.
Wu Y; Zhong L; Geng J
Mult Scler Relat Disord; 2019 Jan; 27():412-418. PubMed ID: 30530071
[TBL] [Abstract][Full Text] [Related]
16. Short myelitis lesions in aquaporin-4-IgG-positive neuromyelitis optica spectrum disorders.
Flanagan EP; Weinshenker BG; Krecke KN; Lennon VA; Lucchinetti CF; McKeon A; Wingerchuk DM; Shuster EA; Jiao Y; Horta ES; Pittock SJ
JAMA Neurol; 2015 Jan; 72(1):81-7. PubMed ID: 25384099
[TBL] [Abstract][Full Text] [Related]
17. Comparison of brain and spinal cord magnetic resonance imaging features in neuromyelitis optica spectrum disorders patients with or without aquaporin-4 antibody.
Fan M; Fu Y; Su L; Shen Y; Wood K; Yang L; Liu Y; Shi FD
Mult Scler Relat Disord; 2017 Apr; 13():58-66. PubMed ID: 28427704
[TBL] [Abstract][Full Text] [Related]
18. Central nervous system inflammatory demyelinating disorders among Hong Kong Chinese.
Chan KH; Lee R; Lee JC; Tse AC; Pang SY; Lau GK; Teo KC; Ho PW
J Neuroimmunol; 2013 Sep; 262(1-2):100-5. PubMed ID: 23838529
[TBL] [Abstract][Full Text] [Related]
19. The Immunology of Neuromyelitis Optica-Current Knowledge, Clinical Implications, Controversies and Future Perspectives.
Jasiak-Zatonska M; Kalinowska-Lyszczarz A; Michalak S; Kozubski W
Int J Mol Sci; 2016 Mar; 17(3):273. PubMed ID: 26950113
[TBL] [Abstract][Full Text] [Related]
20. Anti-MOG antibodies are present in a subgroup of patients with a neuromyelitis optica phenotype.
Pröbstel AK; Rudolf G; Dornmair K; Collongues N; Chanson JB; Sanderson NS; Lindberg RL; Kappos L; de Seze J; Derfuss T
J Neuroinflammation; 2015 Mar; 12():46. PubMed ID: 25889963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
